Research Article
Safety Assessment of Ubiquinol Acetate: Subchronic Toxicity and Genotoxicity Studies
Table 8
Effect of ubiquinol acetate on hematological parameters in female rats.
| Parameters | Units | Group & Dose (mg/kg b.w.) | G1, | G2, | G3, | G4, | G1R, | G4R, | 0 | 150 | 300 | 600 | 0 | 600 |
| Total WBC count | 103/μl | 5.04±1.49 | 4.25 ± 0.99 | 5.13± 1.16 | 5.49±2.89 | 5.03±1.53 | 5.33±1.58 |
| Total RBC count | 106/μl | 8.06±0.33 | 8.31 ± 0.30 | 8.09± 0.27 | 8.08± 0.35 | 8.18±0.32 | 7.94±0.24 |
| Hemoglobin | g/dL | 14.88±0.58 | 15.17±0.46 | 14.65±0.39 | 14.76±0.54 | 15.84±0.29 | 15.54±0.39 |
| Hematocrit | % | 45.24±1.86 | 45.10±1.04 | 43.55±0.92 | 43.54±1.80 | 45.42±1.86 | 43.48±1.00 |
| MCV | fL | 56.12±1.02 | 54.32±1.29 | 53.88±1.85 | 53.94±0.69 | 55.50±0.91 | 54.8±1.80 |
| MCH | pg | 18.47±0.31 | 18.27±0.42 | 18.14±0.71 | 18.31±0.46 | 19.36±0.47 | 19.6±0.24 |
| MCHC | g/dL | 32.90±0.31 | 33.66±0.44 | 33.62±0.52 | 33.95±0.65 | 34.90±0.86 | 35.76±0.85 |
| Neutrophils | 103/μl | 0.99±0.51 | 0.72±0.17 | 1.03±0.49 | 1.35±1.27 | 0.62±0.26 | 0.95±0.42 |
| Lymphocytes | 103/μl | 3.75±1.04 | 3.28±0.83 | 3.81±0.82 | 3.81±1.90 | 4.13±1.54 | 4.05±1.20 |
| Monocytes | 103/μl | 0.12±0.03 | 0.11±0.04 | 0.12±0.03 | 0.14±0.06 | 0.11±0.05 | 0.16±0.04 |
| Eosinophils | 103/μl | 0.11±0.06 | 0.07±0.02 | 0.10±0.07 | 0.11±0.08 | 0.13±0.09 | 0.12±0.06 |
| Basophils | 103/μl | 0.01±0.01 | 0.00±0.00 | 0.01±0.01 | 0.01±0.01 | 0.01±0.01 | 0.01±0.00 |
| LUC | 103/μl | 0.06±0.02 | 0.07±0.03 | 0.07±0.02 | 0.08±0.04 | 0.03±0.01 | 0.04±0.01 |
| Platelet count | 103/μl | 783.10±190.59 | 790.40±263.71 | 691.10±185.00 | 834.80±295.27 | 934.6±240.07 | 858.4±291.48 |
| Blood clotting time | Seconds | 155.80±14.80 | 154.70±14.58 | 158.30±16.23 | 144.50±24.34 | 152.40±16.02 | 214±33.94 |
|
|
Mean ± SD for 10 rats/sex/group (G1, G2, G3, G4) and 5 rats/sex/group (G1R, G4R); : statistically significant compared to the control group (p < 0.05). |